Related Experiment Video
Updated: Jun 17, 2026

12:42
Heterotypic Three-dimensional In Vitro Modeling of Stromal-Epithelial Interactions During Ovarian Cancer Initiation and Progression
Published on: August 28, 2012
15.1K
Neoplasms in Struma Ovarii: A Review
Isabella Tondi Resta1, Christopher M Sande2, Virginia A LiVolsi3
1Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, 19104, USA. isabella.tondiresta@pennmedicine.upenn.edu.
Endocrine Pathology
|October 21, 2023
Summary
Struma ovarii, an ovarian teratoma of thyroid tissue, can rarely harbor malignancy. This review aids pathologists in diagnosing malignant struma ovarii using key markers like TTF1.
Area of Science:
- Gynecologic Pathology
- Endocrine Pathology
- Oncologic Pathology
Background:
- Struma ovarii is a germ cell tumor composed of mature thyroid tissue, typically benign.
- While predominantly benign, struma ovarii can rarely present with malignant transformation.
- Accurate diagnosis is crucial for appropriate patient management and prognosis.
Purpose of the Study:
- To review common malignancies associated with struma ovarii.
- To highlight the diagnostic utility of specific immunohistochemical markers.
- To aid pathologists in the accurate diagnosis of malignant struma ovarii.
Main Methods:
- Review of literature on struma ovarii and its malignant counterparts.
- Discussion of key histopathological features of common struma ovarii malignancies.
- Emphasis on immunohistochemical staining, particularly TTF1, PAX8, and thyroglobulin.
Main Results:
- Common malignant components include papillary thyroid carcinoma, strumal carcinoid, and follicular thyroid carcinoma.
- Immunohistochemistry, especially TTF1, is vital for distinguishing thyroid tissue from ovarian epithelium.
- Normal thyroid tissue in struma ovarii shows characteristic staining for TTF1, PAX8, and thyroglobulin.
Conclusions:
- Malignant transformation in struma ovarii requires careful histopathological evaluation.
- TTF1 staining is a critical tool for differentiating struma ovarii malignancies from ovarian neoplasms.
- This review provides a concise guide for pathologists managing complex struma ovarii cases.

